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Chronic glial activation is characterized by an increased number of activated microglia
and astroglia; these secrete free radicals and cytotoxic cytokines, subsequently causing
neuronal damage. This study investigated the hypothesis that a soy-lecithin based
phytosomal curcumin formulation can decrease glial activation in the brains of GFAP-
IL6 mice, a model of chronic glial activation, which exhibits gliosis in various regions
of the brain. Three doses of Meriva curcumin (MC) (874, 436, and 218 PPM) were
fed to 3-month-old GFAP-IL6 and wild-type (WT) mice for 4 weeks. As markers of
glial activation, the total numbers of Iba-1+ and TSPO+ microglia and macrophages,
and GFAP+ astrocytes, were determined in the cerebellum and hippocampus by
immunohistochemistry and unbiased stereology. Furthermore, the morphology of the
glial cells was assessed by confocal microscopy and Sholl analysis. Administration of
phytosomal curcumin led to a dose-dependent reduction in neuroinflammatory markers.
Phytosomal curcumin (874 PPM) decreased the number of microglia by 26.2% in the
hippocampus and by 48% in the cerebellum of the GFAP-IL6 mice compared with
the GFAP-IL6 mice on normal food. Additionally, GFAP+ astrocyte numbers in the
hippocampus of the GFAP-IL6 mice were decreased by 42%. The GFAP-IL6 mice
exhibited a different microglial morphology to the WT mice, showing an increased
soma size and perimeter. This difference was significantly reduced by the 874 PPM
phytosomal curcumin dose. Our findings demonstrate that phytosomal curcumin is able
to attenuate the inflammatory pathology, and potentially reverse the detrimental effects
of chronic glial activation.
Keywords: microglia activation, astrocytes, Iba-1, TSPO, GFAP, neuroinflammation, stereology
INTRODUCTION
Neuroinflammation is a defense response of the central nervous system (CNS) to injury, infection,
or the presence of toxic metabolites. Acute neuroinflammation is a self-protective reaction aimed at
eliminating harmful stimuli and restoring tissue integrity. However, if neuroinflammation becomes
chronic, it can be harmful. Chronic neuroinflammation is both a feature and a potential cause
Frontiers in Neuroscience | www.frontiersin.org 1 March 2020 | Volume 14 | Article 170
fnins-14-00170 March 11, 2020 Time: 19:57 # 2
Ullah et al. Phytosomal Curcumin Against Chronic Neuroinflammation
of many neurodegenerative diseases such as Alzheimer’s disease
and dementia (Arends et al., 2000). Interleukin 6 (IL-6) is a
pleiotropic, regulatory cytokine that may play a pathogenic role
in dysregulating inflammatory responses (Akira et al., 1990).
Microglia and astrocytes play a key role in the CNS’s innate
immunity. The major function of microglia is to clear damaged
neurons and foreign pathogens, while astrocytes help to remove
debris and toxins from the cerebrospinal fluid. When activated,
microglia and astrocytes produce a variety of proinflammatory
cytokines and neurotoxic factors, such as reactive oxidative
species (ROS), leading to neuronal damage, neuroinflammation
(Wang et al., 2015; Tjalkens et al., 2017), and subsequent cognitive
deficits (Rosenblat et al., 2014; Heneka et al., 2015; Kirkley et al.,
2017). Microglia are the key neuroinflammatory cells as they
are activated in response to brain inflammation and release the
ROS and cytokines that cause neurotoxicity (Beggs and Salter,
2007; Block et al., 2007). TSPO is a translocator protein expressed
in the nervous system, specifically on the outer mitochondrial
membrane (Chen and Guilarte, 2008). It is predominantly
expressed in the microglia, astrocytes, and macrophages in the
blood vessels (Kuhlmann and Guilarte, 2000; Wilms et al., 2003).
TSPO represents a novel macrophage marker, as neurological
insults and chronic neuroinflammation induce TSPO expression
in the nervous system (Kuhlmann and Guilarte, 2000; Casellas
et al., 2002). Astrocytes are cells that are vital to the CNS,
playing an important role in coupling neuronal organization to
blood flow and maintaining, regulating, and altering neuronal
synaptic junctions (Zhang and Haydon, 2005). Astrocytes are
highly reactive cells that respond to adverse neural insults, such as
neuroinflammation, trauma and neurodegeneration (Sofroniew,
2009). Previous studies conducted on GFAP-IL6 mice have
shown a larger number of GFAP+ astrocytes in both the
cerebellum and cortical areas compared with wild type (WT)
mice (Chiang et al., 1994).
Morphological features are one of the important
characteristics of microglial cells. Under normal circumstances,
resting microglia with a ramified morphology continuously
scan the nervous system (Nimmerjahn et al., 2005). During
inflammatory conditions, the microglial cells have been observed
to go into an activated state, where they become amoeboid-
like in their morphology, becoming de-ramified microglia,
which are characterized by a swollen cell body and thick
processes. Similarly, astrocytic morphological changes are a
hallmark of neurodegenerative disease; in certain physiological
conditions, astrocytes have a bushy or spongiform shape,
with fine, delicate processes emerging from the soma. During
neuroinflammation, when astrocytes are activated, they are
characterized by an increase in size, number and thickness
of processes, and an increased level of GFAP expression
(Wilhelmsson et al., 2006).
Curcumin is an active component of turmeric, constituting
2–5% of the spice (Aggarwal et al., 2003). It has low toxicity
and high preclinical efficacy, which makes it a good natural drug
candidate against inflammatory conditions (Burgos-Moron et al.,
2010; Ullah et al., 2017). It is a potent cytokine-suppressive anti-
inflammatory drug (CSAID) and exerts a broad range of anti-
inflammatory effects. Curcumin downregulates the expression
of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase
(iNOS), tumor necrosis factor (TNF-α), IL-1, -2, -6, -8, and
-12 (Abe et al., 1999; Hansen et al., 2010). Initially, results
of clinical trials conducted with curcumin were disappointing,
probably due to the poor bioavailability and rapid metabolism
of the compound (Jurenka, 2009). In order to improve the
bioavailability of curcumin, a variety of curcumin formulations
were developed, including phytosomal Meriva curcumin (MC),
produced by Indena S.p.A, Italy, which consists of curcumin
combined with soy-lecithin (Antiga et al., 2015).
GFAP-IL6 mice have been used in this study as a model of
chronic glial cell activation. In the GFAP-IL6 mouse model,
the murine IL-6 gene is expressed by astrocytes under the
transcriptional control of the glial fibrillary acidic protein
(GFAP) promoter, resulting in brain-specific overexpression of
IL6 and chronic low-grade neuroinflammation, characterized
by microglia and astrocyte activation throughout the lifespan
(Gyengesi et al., 2019). This has been demonstrated via a
significant increase in Iba-1+ and TSPO+ microglia and
macrophages, GFAP+ astroglia and neurodegeneration
predominantly in the cerebellum (Campbell et al., 1993),
leading to the activation of microglia (microgliosis) and
astrocytes (astrocytosis) (Gyengesi et al., 2018) and a range
of structural and functional neurological impairments that
typify various neurodegenerative diseases (Campbell et al.,
1993). Previous studies have reported that GFAP-IL6 transgenic
mice display a high level of IL6 expression in the cerebellum
compared with other brain regions (Campbell et al., 1993;
Quintana et al., 2009). A recent study conducted by our lab
in the same animal model has confirmed that the number
of Iba-1+ cells in GFAP-IL6 mice is significantly larger
compared with that of the WT mice (Gyengesi et al., 2018).
This paper represents the first study to evaluate the effect of
MC in the GFAP-IL6 mouse model. MC could be a potential
suppressive agent against chronic neuroinflammation through
the modulation of astroglial and microglial activity. To
determine how MC affects the number and morphology
of activated (Iba-1+, TSPO+) microglia and activated
(GFAP+) astroglia in the brain, stereological counting and
three-dimensional (3D) reconstruction techniques were
applied to assess reactive and non-reactive microglia and
astrocytes in the hippocampus and the cerebellum in an
unbiased manner.
MATERIALS AND METHODS
Animals
Wild-type (C57BL/6) and GFAP-IL6 mice of mixed genders
weighing 20–30 g were housed in the animal facility of the School
of Medicine, Western Sydney University under a temperature-
controlled environment, with a normal 12 h/12 h light–dark
cycle at 23◦C and 60 ± 10% humidity, and were provided with
food and water ad libitum. The experimental procedures were
approved by the Western Sydney University Animal Care and
Ethics Committee (approval ID: A11393) and carried out in
accordance with the rules established by the National Health
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and Medical Research Council of Australia. Three-month-
old heterozygous GFAP-IL6 mice and their non-transgenic
littermates (WT C57BL/6) were used.
Grouping of Animals and Feeding With
Phytosomal Curcumin Containing Food
Pellets
Animals were randomly assigned to five groups: WT C57BL/6
mice fed with control food pellets, GFAP-IL6 mice fed with
control food pellets and three groups of GFAP-IL6 mice fed
with food pellets containing 874, 436, and 218 PPM of MC
(Table 1 and Supplementary Table S1). Meriva curcumin (MC)
was supplied by Indena S.p.A, Italy, and incorporated into the
mouse chow (Specialty Feeds, Perth, Australia). MC was mixed
with powdered mouse food, and around 15% water was added
before introduced the mixed diet to the pellet machine. In the
pelleting machine, the temperature of the product would not
exceed 43C. After pelleting the moisture content had to be
reduced to stabilize the diet against microbial storage damage.
This was done by loading the pellets into a shallow tray in
an air dryer set at 65C for 3 h. Over the drying cycle the
temperature of the pellets was increased slowly from 25C to
45C. The mouse chow pellets were stored at room temperature
in vacuum packed bags in the animal housing facility at the
School of Medicine, Western Sydney University. At the age of
3 months, the mice were fed for 4 weeks with normal food
or MC. The cage food trays were monitored weekly to record
food consumption. At the age of 4 months, the animals were
perfused for histology.
Histology and Tissue Sample Preparation
For histological analysis, the tissue samples were prepared
from all the experimental cohorts. The mice were anesthetized
with pentobarbitone (30–50 mg/kg i.p.) and were transcardially
perfused with 30 ml of 0.9% normal saline using a peristaltic
pump, followed by 60 ml of 4% cold paraformaldehyde (Merck)
(in 0.1 M phosphate buffer). The brains were harvested and
post-fixed in 4% paraformaldehyde for 24 h at 4◦C, and
then transferred to 30% sucrose (in 0.1 M PB solution) for
cryoprotection. After the brains sank to the bottom of the
container, they were embedded and frozen with 6% gelatin. Forty
µm thick coronal sections were cut in eight series using a Leica
CM 1950 cryostat.
TABLE 1 | Number of mice per cohorts.
Cohort genotype Type of food Number of mice/male/female
(M/F) used
Iba-1 GFAP TSPO
WT Normal food 6 (3M, 3F) 4 (2M, 2F) 6 (3M, 3F)
GFAP-IL6 Normal food 7 (4M, 3F) 4 (2M, 2F) 5 (4M, 1F)
GFAP-IL6 218 PPM MC 7 (3M, 4F) 5 (1M, 4F) 6 (2M, 4F)
GFAP-IL6 436 PPM MC 6 (3M, 3F) 6 (3M, 3F) 5 (2M, 3F)
GFAP-IL6 874 PPM MC 7 (3M, 4F) 7 (3M, 4F) 7 (3M, 4F)
Immunohistochemistry
For bright field microscopy, immunohistochemistry assays were
performed on every eighth section from the brains to identify
the microglial activation using microglia markers (Iba-1 and
TSPO). All washing and incubation procedures were performed
using 0.1 M PBS unless stated otherwise. The sections were
washed three times and treated with 1% H2O2 before being
incubated for 2 h in the blocking solution (2% goat serum)
to block the non-specific antigen-binding sites. They were
then incubated in the primary rabbit-anti-Iba1 antibody (1:500,
Wako, # 019-19741) and rabbit anti TSPO (1:500, Merck,
#ABC139) solutions for 2 days at 4◦C and, subsequently, in
the secondary antibody (1:200, biotinylated goat anti-rabbit IgG;
Life Technologies, #656140) for 2 h. The sections were washed
three times and ABC solution (1:250, Vector Laboratories, # PK-
6100) was applied for 2 h. The sections were then incubated in
the developer solution containing 0.4 mg/ml DAB and 0.0006%
hydrogen peroxide until an optimal color developed. Then,
the sections were washed, mounted, dehydrated, coverslipped,
and their images were captured with a Zeiss microscope
(MBF Bioscience).
Fluorescence Microscopy
Immunofluorescent staining was performed on every eighth
section from the brains to identify the astroglial activation
using GFAP as an astroglial marker. The sections were
washed with 0.1 M PBS in order to remove the gelatin
and were incubated in the primary rabbit-anti-GFAP
antibody (1:500, Dako, #20023331) solution for 1 day at
4◦C, followed by fluorescence secondary antibody (1:200,
goat anti-rabbit IgG, Alexa 488; Thermo Fisher Scientific,
#1853312) for 2 h. The sections were washed, mounted, and
coverslipped with a fluorescent mounting medium (Vector
Laboratories, #H1400).
Stereological Counting
The estimated number of glial cells in both the cerebellum and
the hippocampus was counted on Iba1, TSPO and GFAP stained
sections using the Zeiss AxioImager M2 microscope equipped
with the MBF Biosciences StereoInvestigator (Bastide et al.,
2014). The contour of the cerebellum and the hippocampus was
first drawn under the 2.5x objective. The size of the counting
frame for the WT mice was 130 × 130 µm for the cerebellum
and 120 × 120 µm for the hippocampus. The size of the
counting frame for the GFAP-IL6 mice was 60 × 60 µm for
both the cerebellum and hippocampus. The counting grid was
1500 × 1000 µm for the cerebellum, and 800 × 800 µm for
the hippocampus, for all of the cohorts. The guard zone was
1 µm at the top and the bottom of the sections. Microglia
and astrocytes were plotted on the screen using a marker as
the focus moved from the top to the bottom of the sections
using a 63x oil objective. This led to a Gunderson coefficient
error of less than 0.1 in all cases (m = 1). Due to technical
limitations, it was not possible to discriminate between individual
astrocytes in the cerebellum. Therefore, for this time point, only
the representative pictures are shown. However, the number
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FIGURE 1 | MC decreased the number of Iba-1+ microglia in the hippocampus of GFAP-IL6 mice. (A–E) Representative photomicrographs of immunohistochemical
staining for the microglia (Iba-1+ cells) of the hippocampus. (Magnification 10x objective field, scale bar = 500 µm and 100 µm in inserts). Images are representative
of at least six animals per group (n = 6). (F) Graphical representation of total Iba-1+ count in the hippocampus. The graph represents the mean ± SEM and
significant differences were determined using one-way analysis of variance (ANOVA). Significance = ****p < 0.0001, *p < 0.05.
FIGURE 2 | MC decreased the number of Iba-1+ microglia in the cerebellum of GFAP-IL6 mice. (A–E) Representative photomicrographs of immunohistochemical
staining for the microglia (Iba-1+ cells) of the cerebellum. (Magnification 10x objective field, scale bar = 500µm and 100 µm in inserts). Images are representative of
at least six animals per group (n = 6). (F) Graphical representation of total Iba-1+ count in the cerebellum. The graph represents the mean ± SEM and significant
differences were determined using one-way analysis of variance (ANOVA). Significance = ****p < 0.0001, *p < 0.05.
of GFAP+ cells in the hippocampus was measured under the
above-mentioned parameters.
Three-Dimensional Reconstruction of
Astrocytes and Microglia
Samples were prepared as described above and the images were
taken using a Confocal ZEISS Laser Scanning Microscope (LSM-
5) with an argon laser and processed using the Zen 2009 software
package. The Z-stacks were captured using a 20x objective
and NA1.0 for reflective imaging, at a step size of 0.1 µm
(unless otherwise specified). Reflective imaging was achieved
using the 488 nm wavelength. For the 3D reconstruction of both
astrocytes and microglia, Neurolucida 360 (MBF Bioscience)
software was used. To better identify the objects and provide
greater accuracy, all the images were taken using a 20x high
power objective with the laser scanning confocal microscope.
A total of 16–20 cells in the hippocampus and the cerebellum of
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FIGURE 3 | MC decreased the number of TSPO+ microglial cells/macrophages in the hippocampus of GFAP-IL6 mice. (A–E) Representative photomicrographs of
immunohistochemistry staining for the microglia (TSPO+ cells) of the hippocampus. (Magnification 10x objective field, scale bar = 500 µm and 100 µm in inserts).
Images are representative of at least six animals per group (n = 6). (F) Graphical representation of total TSPO+ microglial/macrophages count in the hippocampus.
The graph represents the mean ± SEM and significant differences were determined using one-way analysis of variance (ANOVA). Significance = *p < 0.01,
****p < 0.0001.
FIGURE 4 | MC decreased the number of TSPO+ microglial cells/macrophages in the cerebellum of GFAP-IL6 mice. (A–E) Representative photomicrographs of
immunohistochemistry staining for the microglia (TSPO+ cells) of the cerebellum. (Magnification 10x objective field, scale bar = 500µm and 100 µm in inserts).
Images are representative of at least six animals per group (n = 6). (F) Graphical representation of total TSPO+ microglial/macrophages count in the cerebellum. The
graph represents the mean ± SEM and significant differences were determined using one-way analysis of variance (ANOVA). Significance = *p < 0.01,
****p < 0.0001.
the brain were traced in each experimental cohort and fully or
partially reconstructed (only soma). After importing the Z-stacks
to Neurolucida 360 software, the astrocytes and microglia were
manually reconstructed along the required planes, obtaining a 3D
image of each cell.
Analysis of Reconstructed Cells
Morphometric data of each astrocyte and microglia were
extracted by the software and thus, each reconstructed cell was
subject to multiple parameters. The soma area, soma perimeter,
convex two-dimensional (2D) area, convex perimeter, the total
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FIGURE 5 | MC decreased GFAP+ astrocytes in the hippocampus of GFAP-IL-6 mice. (A) Representative photomicrographs of immunofluorescence staining for the
astrocytes (GFAP+ cells) in the hippocampus. (Magnification 5x and 63x objective field, scale bar = 100 µm in 5x and 50 µm in 63x). Images are representative of at
least six animals per group (n = 6). (B–F) Graphical representation of total GFAP count in the hippocampus. The graph represents the mean ± SEM and significant
differences were determined using one-way analysis of variance (ANOVA). Significance = *p < 0.05, **p < 0.001, ***p < 0.0001, ****p < 0.0001.
FIGURE 6 | MC decreased GFAP+ astrocytes in the cerebellum of GFAP-IL-6 mice. Representative photomicrographs of immunofluorescence staining for the
astrocytes (GFAP+ cells) in the cerebellum. (Magnification 5x and 63x objective field, scale bar = 100 µm in 5x and 50 µm in 63x). Images are representative of at
least six animals per group (n = 6).
length of all processes, the total volume of all processes, the
total density and the number of nodes (Branch points) and
dendrites of all the processes were measured. In order to
determine changes in the size of the cells in relation to the
distance from the cell soma, Sholl analysis was performed for
each microglial and astroglial cell (Bento-Torres et al., 2017).
The Z-stack images of the live microglia and astrocytes were
condensed into a maximum intensity and applied to the Sholl
analysis in Neurolucida 360 software. Concentric circles (radii)
originating from the soma were spaced 5 µm apart in this case.
This analysis determined the number of intersections, the process
length (µm), the surface area of the cells (µm2), the process
volume (µm3), the process diameter (µm) and a number of
nodes of the cells for each radius.
Data Analysis
The estimated number of microglia and astrocytes in both the
cerebellum and the hippocampus were compared between groups
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using one-way ANOVA in GraphPad Prism 6. The results were
presented as mean± SEM. Significance was indicated when p was
less than 0.05. The distinct morphological features of microglia
and astrocytes in the brain were compared between groups
using a one-way ANOVA with Tukey’s post-test (∗p < 0.05,
∗∗p < 0.001, ∗∗∗p < 0.0001, mean ± SEM). Correlations of the
convex hull area with the distinct morphological features of the
microglia and astrocytes were analyzed using linear regression
(R2) and correlation (∗p < 0.05) tests in GraphPad Prism 7. The
ANCOVA test was used to compare slope differences in each
specific morphological feature (∗p < 0.05) between the different
experimental cohorts.
RESULTS
MC Decreased the Number of Iba-1+
Microglia in the Hippocampus and the
Cerebellum of GFAP-IL6 Mice
Phenotype and feed effects on the number of Iba-1+
microglial cells were determined. Immunohistochemistry
and stereological counting of Iba-1+ microglia were performed
in the hippocampus and cerebellum of GFAP-IL6 mice fed with
normal food or increasing doses of MC.
The hippocampus of the GFAP-IL6 mice fed with normal
food had 438,550 ± 29,717 Iba-1+ microglia, which was
significantly higher than that of the WT mice (175,192± 12,098)
(p < 0.0001) (Figures 1A,B,F). In the MC fed GFAP-IL6
mice, a reduction in the number of Iba-1+ microglia was
observed. The low doses, 218 PPM and 436 PPM, of MC
reduced the number by 17.5% (361,644 ± 20,593) and 22%
(338,483 ± 33,212) (Figures 1C,D,F), whereas 874 PPM of
MC significantly reduced the number of microglia by 26.2%
(323,451 ± 21,520) compared with the GFAP-IL6 normal food
fed cohort (Figures 1E,F).
In the cerebellum, the GFAP-IL6 mice had
1,025,205 ± 104,467 Iba-1+ microglia; this was significantly
higher than that of the WT mice (154,058± 12,871) (p < 0.0001)
(Figures 2A,B,F). A reduction in a total number of microglial
cells was observed in all the MC dose groups compared with the
normal food fed GFAP-IL6 group. The GFAP-IL6 mice fed with
218 PPM, 436 PPM and 874 PPM downregulated the Iba-1+
microglia by 32% (693,938 ± 117,878), 36% (654,996 ± 48,489)
and 40% (605,085± 63,857), respectively (Figures 2C–F).
MC Decreased the Number of TSPO+
Microglial Cells/and Macrophages in the
Hippocampus and Cerebellum of the
GFAP-IL6 Mice
The mitochondrial translocator protein (TSPO) is expressed
in both macrophages and a portion of the microglia in the
brain and has been shown to be upregulated in reactive
microglia during inflammation (Cosenza-Nashat et al., 2009;
Mirzaei et al., 2016). In addition to Iba-1, immunostaining
was performed for TSPO as a microglial marker. Stereological
quantification was performed in order to test whether there
was a difference in TSPO+ microglia/macrophages between
the WT and GFAP-IL6 mice, and whether MC changes
the number of TSPO+ cells in the brains of the GFAP-
IL6 mice.
In the hippocampus, the GFAP-IL6 mice had 147,803± 46,723
TSPO+ microglia/macrophages compared with the WT mice
(4747 ± 3866) (p < 0.0001) (Figures 3A,B,F). The 218 PPM
and 436 PPM doses of MC reduced the number of TSPO+
microglia/macrophages by 16% (123,769 ± 6266) and 19%
(119,213 ± 11,229), respectively. The 874 PPM dose of MC
significantly decreased the number by 33% (98,941 ± 21,413)
(Figures 3C–F).
In the cerebellum, the GFAP-IL6 mice had 369,963 ± 152,991
TSPO+ microglia/macrophages, which was significantly
higher than that of the WT mice (12,402 ± 8820)
(p < 0.0001) (Figures 4A,B,F). Lower doses of MC, such
as 218 PPM and 436 PPM, reduced the number of TSPO+
microglia/macrophages by 26% (276,303 ± 40,166) and 24%
(278,235 ± 35,052), respectively (Figures 4C,D). The 874 PPM
MC reduced TSPO+ microglial/macrophages number by 42%
(215,912 ± 80,444) compared with the GFAP-IL6 normal food
fed mice (Figures 4E,F).
MC Decreased GFAP+ Astrocytes in the
Hippocampus and the Cerebellum of the
GFAP-IL-6 Mice
To quantify the number of astrocytes, GFAP immunostaining
and stereological quantification were performed to investigate
the genotype difference between the WT and GFAP-IL6
mice. The effect of MC on the elevated number of GFAP+
astrocytes in the GFAP-IL6 mice was investigated in the
hippocampus and cerebellum.
In the hippocampus, the GFAP-IL6 mice had a significantly
larger number of GFAP+ astrocytes (530,374 ± 30,447)
compared with the WT mice (169,908 ± 17,046) (p < 0.0001)
(Figures 5A,B,F). In the MC fed GFAP-IL6 mice, a significant
reduction in the number of GFAP+ astrocytes was observed
in a dose-dependent manner compared with the GFAP-IL6
normal fed group. MC at a dose of 218 PPM and 436
PPM reduced the number by 30% (369,401 ± 64,227) and
37% (333,646 ± 85,311), respectively (Figures 5C,D,F). The
874 PPM downregulated the total GFAP+ astrocytes by 42%
(304,668± 62,649) (Figures 5E,F).
In the cerebellum, the astrocytes and their processes
were very abundant and densely packed, making stereological
counting difficult, hence the numbers of GFAP+ cells were
not analyzed. However, high-level expression of GFAP protein
was observed in the GFAP-IL6 mice compared with the WT
mice, located mostly, but not exclusively, in the gray matter of
the cerebellum, with a strong presence of elongated microglia
in the white matter and molecular layer. The difference in
the distribution of astrocytes between the WT and GFAP-
IL6 animals was substantial. Using qualitative observation and
analysis, the MC fed groups appeared to have a comparatively
low expression of GFAP protein compared with the GFAP-IL6
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TABLE 2 | Stereological counting summary.
Cohort genotype Diet Iba-1
hippocampus
(Mean ± SEM)
Iba-1 cerebellum
(Mean ± SEM)
TSPO
hippocampus
(Mean ± SEM)
TSPO cerebellum
(Mean ± SEM)
GFAP
hippocampus
(Mean ± SEM)
WT Normal food 175,192 ± 12098 154,058 ± 12871 4,747 ± 1579 12,402 ± 3,601 169,908 ± 8,523
GFAP-IL6 Normal food 438,550 ± 29,717 1,025,205 ± 104,467 147,803 ± 20,895 369,963 ± 68,420 530,374 ± 15,224
GFAP-IL6 218 PPM MC 361,644 ± 20,593 693,938 ± 117,878 123,769 ± 6,266 276,303 ± 40,166 369,401 ± 28,724
GFAP-IL6 436 PPM MC 338,483 ± 33,212 592,373 ± 48,489 119,213 ± 11,229 278,235 ± 35,052 333,646 ± 34,828
GFAP-IL6 874 PPM MC 323,451 ± 21,520 605,085 ± 63,857 98,941 ± 8,094 215,912 ± 30,405 304,668 ± 23,679
group (Figure 6). Summary of the stereological counting is
presented in Table 2.
Correlation Analysis Among the Iba-1+
Microglia, TSPO+
Microglia/Macrophages, and GFAP+
Astrocytes
To investigate whether the numbers of Iba-1+ microglia, TSPO+
microglia/macrophages and GFAP+ astrocytes correlate within
the cohorts, the Iba-1+ microglial count was plotted against the
TSPO+ cell count. A strong correlation was observed between
the two markers in both the cerebellum (R = 0.76, p < 0.0001)
and hippocampus (R = 0.54, p < 0.0015) (Figures 7A,B).
There was also a strong correlation between the Iba-1+
microglial number and the GFAP+ astrocytes number (R = 0.50,
p < 0.0025) in the hippocampus (Figure 7C). Additionally,
the numbers of TSPO+ microglia/macrophages and GFAP+
astrocytes were also correlated in the hippocampus (R = 0.54,
p < 0.0001) (Figure 7D).
Effect of MC on the Morphological
Characteristics of Microglial Cells in the
Hippocampus and Cerebellum
In order to demonstrate how chronic inflammation affects
the morphology of the microglia, we analyzed the anatomical
features of the Iba-1+ microglia in the WT and GFAP-IL6
FIGURE 7 | Correlation analysis among the Iba-1+ microglia, TSPO+ microglia/macrophages, and GFAP+ astrocytes. (A) Graphical representation of the correlation
between Iba-1+ microglia and TSPO+ cells in hippocampus. The data were analyzed using linear regression and correlation. ∗∗p < 0.001, R2 = 0.29 (n = 31)
(B) Graphical representation of the correlation between Iba-1+ microglia and TSPO+ cells in the cerebellum. The data were analyzed using linear regression and
correlation. ∗∗∗∗p < 0.0001, R2 = 0.58 (n = 31) (C) Graphical representation of the correlation between Iba-1+ microglia and GFAP+ astrocytes in hippocampus.
The data were analyzed using linear regression and correlation. ∗∗p < 0.002, R2 = 0.25 (n = 34) (D) Graphical representation of the correlation between TSPO+
microglia/macrophages and GFAP+ astrocytes in hippocampus. The data were analyzed using linear regression and correlation. ∗∗∗∗p < 0.0001, R2 = 0.54 (n = 30).
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FIGURE 8 | Effect of MC on the morphological characteristics of microglial cells in the hippocampus. (A) Morphological assessment of reactive and non-reactive
microglia in the hippocampus. (B–H) Microglia in the inflamed mice have significantly larger soma area, soma perimeter and processes compared with the WT mice.
High dose MC significantly reduced soma area and soma perimeter compared with GFAP-IL6 mice. However, the same high dose MC significantly increased the
number of nodes compared with the GFAP-Il6 mice. It has no effect on the convex area, convex perimeter, dendritic length and number of processes.
Significance = *p < 0.05, **p < 0.001, ***p < 0.0001, ****p < 0.0001.
animals in the hippocampus and cerebellum. To investigate
the effects of MC on microglia morphology, the GFAP-
IL6 mice fed with MC at different doses were included
in the analysis.
In the hippocampus, a difference between the genotypes
was observed, as Iba-1+ microglial cells of the GFAP-IL6
mice had significantly larger soma areas (66.36 ± 22.63 µm2)
(p < 0.004), soma perimeters (33.93 ± 8.18 µm) (p < 0.004)
and more processes (5.62 ± 1.84) (p < 0.05) than those of the
WT mice [soma area (30.005 ± 13.93 µm2), soma perimeter
(20.63 ± 5.50 µm) and number of processes (3.66 ± 1.36)]. The
GFAP-IL6 mice fed with a 874 PPM dose of MC had significantly
decreased soma perimeter (25.47 ± 3.44) and increased number
of nodes compared with the GFAP-Il6 mice on normal food
(10.75 ± 3.49) (Figure 8 and Table 3). The rest of the lower
MC doses did not result in significant changes in any of the
measured parameters.
In the cerebellum, the microglial cells of the GFAP-IL6 mice
fed with normal food displayed significantly larger soma areas
(66.64 ± 12.62) (p < 0.0001) and soma perimeters (33.3 ± 2.84)
(p < 0.0001) as compared with those of the WT mice [microglial
soma area (30.03 ± 8.64) and soma perimeter (20.55 ± 0.28)].
In the MC fed mice, 436 PPM MC also reduced the soma
perimeter of the microglia, while the 874 PPM dose significantly
reduced the soma area (42.48 ± 12.69) (p < 0.0001) and soma
perimeter (26.3 ± 6.52) (p < 0.0001), whereas it significantly
increased the convex area (1617.23 ± 617.94) (p < 0.01), convex
perimeter (156.31 ± 56.31) (p < 0.01), and dendritic length of
the microglia (235.22 ± 35.73) (p < 0.05) compared with the
GFAP-IL6 controls (Figure 9 and Table 3). The rest of the lower
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TABLE 3 | Morphological analysis of Iba-1+ microglia.
Cohorts Diet Soma area (µm)2
(Mean ± SEM)
Soma perimeter
(µm)
(Mean ± SEM)
Convex 2D (area)
(µm)2
(Mean ± SEM)
Convex perimeter
(µm)
Mean ± SEM)
H C H C H C H C
WT Normal food 30.005 ± 5.68 30.03 ± 3.52 20.63 ± 2.24 20.55 ± 1.34 1183.93 ± 171 1197.53 ± 126.4 136.4 ± 8.50 140.93 ± 4.69
GFAP-IL6 Normal food 66.36 ± 8.0 66.64 ± 4.46 33.93 ± 2.89 33.3 ± 1.00 1067 ± 128.8 1014.54 ± 178.3 128.78 ± 7.84 121.73 ± 11.26
GFAP-IL6 218 PPM MC 63.82 ± 6.89 55.34 ± 5.30 33.43 ± 2.52 31.11 ± 2.54 1216.13 ± 119.8 1040.06 ± 33.3 137.88 ± 8.59 126.73 ± 1.87
GFAP-IL6 436 PPM MC 46.57 ± 3.31 47.62 ± 4.11 27.63 ± 1.16 26.5 ± 1.19 1446.16 ± 205.5 1570.76 ± 60.69 150.95 ± 10.72 154.92 ± 3.21
GFAP-IL6 874 PPM MC 42.55 ± 3.34 42.48 ± 4.48 25.47 ± 1.21 26.3 ± 1.60 1277.96 ± 99.78 1617.23 ± 218.1 139.21 ± 5.97 156.31 ± 12.2
Cohorts Diet Total length of
dendrites (µm)
(Mean ± SEM)
Nodes
(Mean ± SEM)
Dendrites
(Mean ± SEM)
H C H C H
WT Normal food 215.15 ± 16.99 208.81 ± 20.25 5 ± 0.51 4.33 ± 0.91 3.66 ± 0.55 4.33 ± 0.42
GFAP-IL6 Normal food 201.55 ± 17.47 168.81 ± 24.81 4.62 ± 0.73 4.75 ± 0.67 5.62 ± 0.65 5.25 ± 0.25
GFAP-IL6 218 PPM MC 196.47 ± 16.59 172.06 ± 14.33 5.37 ± 1.01 5.62 ± 1.14 6.12 ± 0.29 4.5 ± 0.5
GFAP-IL6 436 PPM MC 219.16 ± 18.29 226.28 ± 9.20 5.87 ± 0.54 8.12 ± 1.21 4.75 ± 0.55 5.25 ± 0.52
GFAP-IL6 874 PPM MC 247.0 ± 20.44 235.22 ± 23.6 10.75 ± 1.23 7.37 ± 1.08 4.75 ± 0.49 6.87 ± 0.58
H, hippocampus, C, cerebellum.
MC doses did not result in significant changes in any of the
measured parameters.
Sholl analysis, a quantitative analysis to investigate the
morphological characteristics, of the microglial cells from
the hippocampus and the cerebellum revealed some further
variations in morphology between the WT and GFAP-IL6
normal food fed, GFAP-IL6 MC fed mice characteristics. In
the hippocampus, the microglia of the GFAP-IL6 mice have
a significantly larger surface area (p < 0.03), process volume
(p < 0.0006), and process diameter (p < 0.0004) than that of
WT mice. In the MC fed mice, the 218 PPM and 436 PPM
dose significantly reduced the process volume and diameter,
whereas the 874 PPM dose significantly decreased the process
volume (p < 0.0006) and surface area (p < 0.03), while it
significantly increased the number of nodes (p < 0.02) compared
with the microglia of normal fed GFAP-IL6 mice (Figure 10).
In the cerebellum of the GFAP-IL6 mice, the Iba-1+ microglia
have a significantly smaller surface area (p < 0.002), process
volume (0.0008), and process diameter (0.001) compared with
microglia of the WT mice. In the MC fed mice, the 218 PPM
dose significantly downregulated the surface area (p < 0.02)
and process volume (p < 0.01), while the 874 PPM dose
significantly reduced the surface area (p < 0.002), process volume
(p < 0.0008), and the process diameter (p < 0.0013) of the
microglia compared with the microglia of non-fed GFAP-IL6
mice (p < 0.01) (Figure 11).
In the hippocampus, correlation analysis of microglial cell
size with each morphological characteristic revealed significant
correlations with soma area in the WT and 436 PPM dose, with
convex perimeter in all cohorts, and with dendritic length in the
curcumin-treated cohorts, which revealed that microglial cells of
the WT and 436 PPM fed groups tended to increase the size
of the soma area. It also suggests that the convex perimeter
of the microglia of each cohort increased with the increasing
size of the cells, whereas the dendritic lengths of the microglia
of the fed cohorts were increased with the overall cell size.
Despite these changes, soma area, soma perimeter, nodes and
number of dendrites of microglia of all treated cohorts remained
consistent regardless of the cell size (Figure 12 and Table 4).
In the cerebellum, some significant correlations were observed
between the soma area and the dendritic length of the GFAP-
IL6 microglia, whereas additional significant correlations were
observed in the convex perimeter in each cohort, showing that
the soma area and dendritic length of microglia change with
the overall cell size, while the convex perimeter increases with
the overall increase in microglial cells. The remaining perimeter
measures had no effect and remained consistent regardless of the
cell size (Figure 13 and Table 5).
Effect of MC on the Morphological
Characteristics of Astrocytes in the
Hippocampus
During inflammation, astrocytes are thought to undergo
cellular hypertrophy and increased the thickness of their main
cellular processes. In order to investigate the difference in
morphology of the astrocytes between the WT and GFAP-
IL6 normal food fed mice, the GFAP-IL6 normal food and
the different doses of MC food fed mice, the morphology of
astrocytes was characterized in the hippocampus. Figures 14A–
F demonstrates the representative images of astrocytes
immunostained for GFAP in the hippocampus. The astrocytes
in the GFAP-IL6 normal food fed mice had significantly a larger
convex area (1247.74 ± 371.77 µm2) (p < 0.0001), convex
perimeter (142.27 ± 26.27 µm) (p < 0.0001), dendritic length
(224.35 ± 66.24 µm) (p < 0.0001), and number of nodes
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FIGURE 9 | Effect of MC on the morphological characteristics of microglial cells in the cerebellum. (A) Morphological assessment of reactive and non-reactive
microglia in the cerebellum. (B–H) In the cerebellum, microglia in the inflamed mice have significantly high soma area and soma perimeter compared with the WT
microglia. MC significantly reduced the soma area while, MC high and medium dose with the normal curcumin significantly decreased the soma perimeter, whereas
only the high dose MC significantly increase the convex area, convex perimeter, and dendritic length compared with the GFAP-IL6 mice. One-way ANOVA, Tukey’s
post-test, Significance = *p < 0.05, **p < 0.001, ****p < 0.0001, mean ± SEM).
(7.33± 2.49) (p < 0.0001), when compared with astrocytes of the
WT mice [convex area (601.93± 201.46 µm2), convex perimeter
(95.04 ± 27.79 µm), dendritic length (107.68 ± 29.17 µm) and
number of nodes (4.68 ± 1.0). In contrast, the 436 PPM dose
significantly decreased the dendritic length (160.85 ± 30.96 µm)
(p < 0.002) and the number of nodes (4.46 ± 1.94) (p < 0.02),
whereas the 874 PPM fed MC significantly decreased the
convex area (857.27 ± 200.79 µm2) (p < 0.02), dendritic length
(139.72 ± 32.87 µm) (p < 0.002), and the number of nodes
(3.86± 2.61) (p < 0.02) (Table 6).
Furthermore, the morphology of astrocytes was quantified
by Sholl analyses. As expected from the data presented, this
analysis revealed some phenotype differences in the number of
intersections, processes lengths, surface areas, and a number of
nodes, which were significantly larger in the GFAP-IL6 mice
compared with the WT mice. In addition, it was found that both
the 436 PPM and 874 PPM MC doses significantly decreased the
process length. Interestingly, the 218 PPM MC dose increased the
surface area, while all doses resulted in increased process volume
and length of the processes compared with the non-fed GFAP-
IL6 mice. No effects of MC were observed in the number of
nodes (Figure 15).
The bivariate correlations of morphological characteristics
were performed with overall astroglial cell size to investigate
the impact of the size of the astroglial cells on the structural
parameters. Some positive correlations of the astroglial cell size
with morphological parameters were observed. Soma area and
soma perimeter of astrocytes in the 218 PPM MC group changed
significantly with the overall change in the entire cells. The
convex perimeter and dendritic length of all cohorts changed
with the overall changes in astrocytes. It was also observed that
the number of nodes in the astrocytes of the 218 PPM and 874
PPM fed cohorts decreased when the overall size of the astrocytes
decreased. In the case of primary dendrites, both the 436 PPM
and 874 PPM doses positively decreased them with the decrease
in the overall cell size of astrocytes (Figure 16 and Table 7).
Taken together, the morphological analyses of the study have
revealed that the highest MC dose was able to decrease astrocyte
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FIGURE 10 | MC retracted the size of microglial cells in the hippocampus. A Sholl analysis revealed a significant change in the surface area, processes volume and
processes diameter of microglia between wild type and GFAP-IL6 inflamed microglia both in the hippocampus. (A–F) MC retracted processes volume and
processes diameter compared with the GFAP-IL6 mice. This can be observed in the peaks of the distributions of different morphological features being closer to the
center compared with the WT and GFAP-IL6 mice, we call it X at Ymax. One-way ANOVA test. Significance = *p < 0.05, ***p < 0.0001.
FIGURE 11 | MC retracted the size if microglial cells in the cerebellum. A Sholl analysis revealed a significant change in the surface area, processes volume and
processes diameter of microglia between wild type and GFAP-IL6 inflamed microglia both in the cerebellum. (A–F) MC retracted surface area, processes volume and
processes diameter compared to the inflamed microglia. This can be observed in the peaks of the distributions of different morphological features being closer to the
center compared with the WT and GFAP-IL6 mice, we call it X at Ymax. One-way ANOVA test.
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FIGURE 12 | Bivariate correlation: MC effects on morphology are dose-independent in the hippocampus. (A–F) Different morphological parameters have been
plotted against convex hull area to see the bivariate correlation between WT, GFAP-IL6 and between non-treated and treated ones. We found that the convex
perimeter of both wild type and GFAP-IL6 are significantly correlated, whereas treatment with any dose of MC showed significant correlation of convex perimeter and
dendritic length relative to convex hull area in the hippocampus. ANCOVA and sum-of-squares tests.
TABLE 4 | Bivariate correlation of morphological characteristics with overall microglial cell size in the hippocampus.
Soma area Soma perimeter Convex perimeter Dendritic length Nodes Primary dendrites
Cohort Diet R2 Correlation R2 Correlation R2 Correlation R2 Correlation R2 Correlation R2 Correlation
WT Normal food 0.67 *0.0453 0.58 0.0756 0.98 ****<0.0001 0.61 0.0665 0 0.9718 0.2 0.3629
GFAP-IL6 Normal food 0.08 0.4881 0.05 0.5626 0.92 ***0.0001 0.23 0.2200 0 0.8238 0 0.9851
GFAP-IL6 218 PPM MC 0.47 0.0586 0.12 0.3955 0.95 ****<0.0001 0.72 **0.0075 0.35 0.1211 0 0.9949
GFAP-IL6 436 PPM MC 0.58 *0.0281 0.38 0.1032 0.87 ***0.0006 0.8 **0.0023 0.01 0.7821 0.21 0.2502
GFAP-IL6 874 PPM MC 0.16 0.3164 0.16 0.3178 0.95 ****<0.0001 0.78 **0.0035 0.05 0.5621 0.4 0.0905
FIGURE 13 | Bivariate correlation: MC effects on morphology are dose-independent in the cerebellum. (A–F) Different morphological parameters have been plotted
against convex hull area to see the bivariate correlation between the WT, GFAP-IL6 and between non-treated and treated ones. We found that medium and a high
dose of MC showed a significant correlation in convex perimeter relative to convex hull area in cerebellum ANCOVA and sum-of-squares tests.
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TABLE 5 | Bivariate correlation of morphological characteristics with overall microglial cell size in cerebellum.
Soma area Soma perimeter Convex perimeter Dendritic length Nodes Primary dendrites
Cohorts Diet R2 Correlation R2 Correlation R2 Correlation R2 Correlation R2 Correlation R2 Correlation
WT Normal food 0.13 0.4787 0.04 0.6975 0.77 *0.0204 0.59 0.0709 0.88 **0.0054 0.05 0.6602
GFAP-IL6 Normal food 0.72 **0.0076 0.26 0.1937 0.95 ****<0.0001 0.94 ****<0.0001 0.06 0.5462 0.04 0.6103
GFAP-IL6 218 PPM MC 0.04 0.6193 0 0.9659 0.46 0.0636 0 0.835 0.06 0.5371 0.08 0.4734
GFAP-IL6 436 PPM MC 0.02 0.7305 0.08 0.471 0.78 **0.0035 0 0.9741 0.04 0.6067 0.17 0.2969
GFAP-IL6 874 PPM MC 0.05 0.5692 0.07 0.5112 0.97 ****<0.0001 0.09 0.4469 0.2 0.2572 0.02 0.6960
FIGURE 14 | Effect of MC on the morphological characteristics of astrocytes in the hippocampus. (A) 3D reconstruction of astrocytes in WT and GFAP-IL6 in both
treated and non-treated mice. (B–H) Astrocytes in the inflamed mice have a significantly high convex area, convex perimeter, dendritic length and nodes compared
with the WT. High dose MC significantly decreased the convex area, dendritic length, and nodes, whereas the medium dose also significantly decreased both the
dendritic length and number of nodes compared with the GFAP-IL6. One-way ANOVA, Tukey’s post-test, Significance = *p < 0.05, **p < 0.001, ****p < 0.0001
(mean ± SEM).
activation and reduced its size similar to that of the astrocytes
in the WT mouse.
DISCUSSION
Chronic neuroinflammation is considered to be one of the
major contributing factors in the progression of various
neurodegenerative diseases, such as dementia, Alzheimer’s and
Parkinson’s disease (Van Eldik et al., 2007). This study suggests
that the cytokine-suppressive anti-inflammatory drug curcumin
is able to downregulate chronic glial activation and protect
against inflammation-induced neuronal damage, as we have
previously suggested (Venigalla et al., 2016). Curcumin, a
common spice, has been used for many decades as a drug
for numerous inflammatory disorders. Despite its various
pharmacological and therapeutic activities, curcumin’s poor
absorption, low permeability, and low bioavailability have limited
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TABLE 6 | Morphological analysis of GFAP+ astrocytes in the hippocampus.
Cohorts Diet Soma area
(µm)2
(Mean ± SEM)
Soma perimeter
(µm)
(Mean ± SEM)
Convex 2D
(area) (µm)2
(Mean ± SEM)
Convex perimeter
(µm)
Mean ± SEM)
Total length (µm)
(Mean ± SEM)
Nodes
(Mean ± SEM)
Dendrites
(Mean ± SEM)
WT Normal food 16.84 ± 1.36 14.13 ± 0.84 601.93 ± 50.37 95.04 ± 6.94 107.68 ± 7.29 2.56 ± 0.36 4.68 ± 0.25
GFAP-IL6 Normal food 13.96 ± 2.48 13.93 ± 1.04 1247.74± 82.95 142.27 ± 5.88 224.35 ± 14.95 7.33 ± 0.58 6.08 ± 0.34
GFAP-IL6 218 PPM MC 11.20 ± 1.23 13.86 ± 0.76 1275.35± 93.23 135.63 ± 5.04 249.12 ± 15.79 8.33 ± 0.65 5.77 ± 0.29
GFAP-IL6 436 PPM MC 18.67 ± 1.48 18.10 ± 0.99 1064.34± 75.74 131.48 ± 4.52 160.85 ± 7.52 4.46 ± 0.45 4.69 ± 0.40
GFAP-IL6 874 PPM MC 14.16 ± 1.39 16.34 ± 0.82 857.27 ± 51.17 120.36 ± 3.20 139.72 ± 7.98 3.86 ± 0.66 4.8 ± 0.33
FIGURE 15 | MC increased the ramification of astrocytes in the hippocampus region. (A–F) A Sholl analysis confirmed a significant increase in the number of the
intersection, processes length, surface area, and a number of nodes compared with the WT. In contrast, MC significantly affects the inflamed astrocytes, which is
observed in the peaks of the distributions of different morphological features being closer to the center compared with the WT and GFAP-IL6 mice, we call it X at
Ymax. One-way ANOVA test. Significance = *p < 0.05, **p < 0.001, ***p < 0.0001, ****p < 0.0001.
TABLE 7 | Bivariate correlation of morphological characteristics with overall astroglial cell size in the hippocampus.
Soma area Soma perimeter Convex perimeter Dendritic length Nodes Primary dendrites
Cohorts Diet R2 Correlation R2 Correlation R2 Correlation R2 Correlation R2 Correlation R2 Correlation
WT Normal food 0.02 0.5654 0 0.8276 0.93 ****<0.0001 0.42 **0.0064 0.03 0.4794 0.01 0.6605
GFAP-IL6 Normal food 0 0.8855 0.01 0.63 0.88 ****<0.0001 0.52 **0.0014 0.02 0.561 0.27 *0.0375
GFAP-IL6 218 PPM MC 0.56 ***0.0001 0.48 ***0.0006 0.97 ****<0.0001 0.88 ****<0.0001 0.53 ***0.0003 0.11 0.139
GFAP-IL6 436 PPM MC 0.01 0.6311 0.01 0.6725 0.82 ****<0.0001 0.33 *0.018 0.15 0.1357 0.3 *0.0272
GFAP-IL6 874 PPM MC 0.04 0.4396 0.07 0.2938 0.79 **** < 0.0001 0.65 ***0.0001 0.03 0.4876 0.13 0.1603
its therapeutic effects. To overcome these limitations, a number
of different formulations have been created to increase its
absorption or inhibit its metabolization, such as the addition
of piperine, formulation of liposomal curcumin, curcumin
nanocapsules and phospholipid curcumin complexes (Anand
et al., 2007; Tsai et al., 2011). Studies have reported that
curcumin can exert a broad range of anti-inflammatory effects
in the CNS (Abe et al., 1999; Drion et al., 2018). Curcumin
preparations, such as Longvida R© (VS Corp), have achieved higher
concentrations in the brains of mice compared with normal
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FIGURE 16 | Bivariate correlation: MC effects on astrocytes morphology are dose independent in the hippocampus. (A–F) Different morphological parameters have
been plotted against convex hull area to see the bivariate correlation between the WT, GFAP-IL6 and between nontreated and treated astrocytes. The analysis
revealed that the convex perimeter and dendritic length are significantly correlated irrespective of the MC dose, whereas in the case of a low dose of MC, soma area,
soma perimeter and nodes while the primary dendrites in medium dose, are significantly correlated relative to convex hull area. Analyzed by ANCOVA and
sum-of-square tests.
curcumin, and in human subjects, led to significantly improved
working memory and mood after a 4-week treatment in a
randomized, double-blind, placebo-controlled trial (Begum et al.,
2008; Wu et al., 2014). In this study, MC was fed to the
GFAP-IL6 mice to investigate the potential therapeutic effects of
MC in chronic neuroinflammation. In this model, the murine
IL-6 gene is expressed in astroglia under the transcriptional
control of the murine glial fibrillary acidic protein (GFAP)
promoter, resulting in cytokine-induced low-grade chronic
neuroinflammation (Campbell et al., 1993) presenting with
microglial activation and increased levels of pro-inflammatory
markers throughout the life span (Gyengesi et al., 2019). Using
this model, the anti-inflammatory effects of three doses of
MC were investigated compared with the normal fed GFAP-
IL6 mice.
After feeding the mice with MC for 4 weeks, it was
observed that MC reduced the number of Iba-1+ microglia
in the cerebellum and the hippocampus, with the high dose
of MC resulting in the most substantial decrease. Previous
studies have reported that the numbers of Iba-1+ microglia
and GFAP+ astrocytes in the mouse brain increase in chronic
neuroinflammatory conditions, which were significantly reduced
after being treated with anti-inflammatory drugs such as
Tenilsetam (Gyengesi et al., 2018). A recent study conducted
in 5 x FAD mice, a mouse model of familial Alzheimer’s
disease, has reported the protective effect of a solid lipid
curcumin formulation (Maiti et al., 2018). They used Image-
J software to count the number of GFAP+ and Iba-1+ cells
and reported that the curcumin formulation was able to
significantly downregulate the microglial and astroglial numbers
in different regions of the hippocampus in the mice brains
(Maiti et al., 2018). Furthermore, they reported that their
formulation of curcumin has higher permeability into brain tissue
and superior therapeutic effects in relation to the reduction
of amyloid plaque formation relative to normal curcumin
(Maiti et al., 2018).
Our study found that the total estimated number of TSPO+
cells in the cerebellum and the hippocampus was significantly
larger in the GFAP-IL6 group compared with the WT group.
The 874 PPM dose of MC significantly reduced TSPO+ cell
number in the GFAP-IL6 mice in both the hippocampus and the
cerebellum compared with the non-fed group. A study conducted
in mice that measured the fluorescence intensity and the number
of TSPO+ cells supports our findings, wherein the number
of Iba-1+ and TSPO+ microglia/macrophages in the GFAP-
IL6 mice was significantly larger compared with the WT mice
(Bonsack et al., 2016).
Additionally, all three doses of MC significantly decreased the
number of reactive astrocytes in the hippocampus compared with
the GFAP-IL6 control mice in a dose-dependent manner.
Within our cohorts, WT, GFAP-IL6, and GFAP-IL6 MC
treated microglial morphologies were characterized in GFAP-
IL6 mice, which revealed certain characteristics of microglia
not reported elsewhere. The present study has identified that
the microglial soma area and soma perimeter significantly
increased in both the hippocampus and cerebellum of the
GFAP-IL6 mice compared with those of the WT’s. Additionally,
there was a significantly larger number of processes in the
microglia of the inflamed brains compared with the non-
inflamed brains. MC altered the morphology of the microglial
cells. The high dose MC significantly reduced the soma
area and soma perimeter, while it significantly increased the
number of nodes in the hippocampus. In the cerebellum,
the high dose MC significantly reduced the soma area and
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soma perimeter, while it increased the convex area, convex
perimeter, and dendritic length compared with the non-fed
control. In short, the MC modified morphology toward that of
the microglia in the WT mice.
Ramified microglia function in a highly dynamic manner,
constantly surveying the neuronal environment for homeostatic
and infective changes and protecting hippocampal neurons
under pathological conditions (Vinet et al., 2012). It has
been reported that microglial cells are activated in response
to many types of neuronal injury or inflammation, and
undergo morphological transformations (Nimmerjahn et al.,
2005). Moreover, resting microglia have the ability to facilitate
prompt reactions to brain injury (Nolte et al., 1996). Studies
have shown that changes in microglial cell size can influence
the entire morphology in response to different challenges to
the CNS (Hinwood et al., 2013). A recent study conducted in
mice has shown that curcumin can reduce the aggregation
and ramification of microglial cells in the hippocampus. They
reported that the microglia were more aggregated in the vehicle-
treated group, while, after injecting solid lipid curcumin to
the mice for 5 days, they noticed a significant reduction in
microglial aggregation, activation, and branch number (Maiti
et al., 2018). Herein, morphological investigations of astrocytes
in the hippocampus have shown that astrocytes of GFAP-IL6
mice have significantly longer dendrites compared with those
of the WT mice, and the high and medium dose of MC
significantly decreased the dendritic length. Moreover, the convex
area of the inflamed astrocytes was also significantly larger
than that of the WT-type mice cells, with the high dose MC
significantly decreasing the convex area. Emerging studies have
reported that curcumin can inhibit the hypertrophy of astrocytes
in the CNS. One such study has reported that a curcumin
formulation was able to decrease astrocyte activation and the
number of branches of the astrocytes in the rat hippocampus
(Cerbai et al., 2012). Similarly, another study conducted in a
rat injury model has reported a decrease in hypertrophy of
astrocytes after been treated with curcumin (Ji et al., 2013;
Maiti et al., 2018).
One of the limitations of the study, however, is that the heating
and melting of phytosomal curcumin during while in contact
with powdered chow could potentially destroy the phytosome
when the liquified phospholipids can interact with chow particles.
Altogether, our study has demonstrated that MC is
able to downregulate chronic neuroinflammation in the
GFAP-IL6 mouse brain measured by various markers of
neuroinflammation.
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